Wepresentacaseofa52-year-oldmanwithmyastheniagravisandamediastinal tumor who was admitted to our hospital for surgical treatment. The pathologic examinationoftheresectedtumorrevealedaveryrarecaseofacollisiontumor: a B1B2 thymoma and a small lymphocytic lymphoma. Flow cytometry of the peripheralbloodrevealedthepresenceofasmallnumberofleukemiccells.After postoperative irradiation of the mediastinum and chemotherapy a complete responseinbothdiseaseswasachieved.Thecaseconfirmsthatapathologistshould alwaysbeawarethattwodifferentneoplasmscancoexistinrarecases.
Introduction
Thymomas are rare mediastinal tumors composed of neoplastic epithelial cells of thymus intermingled withnon-neoplasticimmatureTlymphocytes(thymocytes).Theproportionsofthecellsvarydependingon thehistologicaltypeofathymoma.B-cellsareuncommon and usually dispersed around vessels. The only exception is micronodular thymoma, which contains prominent lymphocyte B-rich stroma and the very characteristic,nodular,architectureofepithelialcells.
Anassociationbetweenthethymomasandsubsequentsecondmalignanciesincludinglymphomashas beenobservedbysomeauthors [1, 2, 3] .However, casesofcoincidenceofthymomaandlymphomaare veryrarelydiscussedintheliterature.Suchcasescan posebothdiagnosticandtherapeuticissues.
Wewouldliketopresentacaseofacollisiontumoroftwodifferentclinicallybuthistologicallysimilar neoplasms: B1B2 thymoma and small lymphocyticlymphoma(SLL).
Case presentation Clinical history
A52-year-oldmanwitha6-monthhistoryofmyasthenic symptoms and an anterior mediastinal tumorwasadmittedtoourhospitalforsurgicaltreatment.Thetumorwaswell-delineatedonacomputed tomography(CT)scanandnoenlargedmediastinal lymphnodesweredescribed.Onadmission,thepatientwasinagoodgeneralconditionandpresented no symptoms except a slight left-sided ptosis. Peripherallymphnodeswerenotenlargedonphysical examination. Preoperative blood analysis revealed aslightelevationofthelymphocytecount(5.14× 10 9 /l), but the total white blood cell count, as well asotherroutinelaboratorytestresults,werenormal.
Thepatientunderwentalongitudinalsternotomy andathymectomyalongwitharesectionofthemediastinalfattissueandregionallymphnodes.
The resected surgical specimen comprised a thymus with a solid, lobulated tumor measuring 7 × 5 × 3.5 cm, as well as fat tissue and 14 mediastinallymphnodes.Boththethymusandlymphnodes wereevenlyfirmandwhiteoncrosssection.
Histological examination
Representative formalin-fixed cut specimens obtained from the surgical material were routinely embeddedinparaffinandhistologicalsectionswere stained with hematoxylin-eosin (HE). After micro-scopic examination, a comprehensive panel of immunohistochemical reactions in BenchMark GX automatedimmunostainer(VentanaMedicalSystem Inc., Tucson, Arizona) was performed and included thefollowingantibodies:pancytokeratin(cloneAE-1AE3,VentanaMedicalSystems,VMS),CD3(clone 2GV6,VMS),CD20(cloneL26,VMS),CD20(clone L26,DAKO)andKi-67(clone30-9,VMS).
Histological classifications of the World Health Organization (WHO) [4, 6] were used to establish thehistologicaltypeoftheneoplasms,andthestage of the thymic epithelial tumor was determined by employingtheMasaoka-Kogastagingsystem.
A microscopic examination revealed the coexistence of two neoplasms: thymoma and SLL. The thymic tumor visible macroscopically represented mostly the thymoma. The tumor was composed of lymphocyte-rich areas without discernible epithelial cellsandperivascularspacesbutwithpreservedcortico-medullarydifferentiationthatresemblednormal thymicarchitecture.However,therewerealsoareas rich in polygonal epithelial cells that formed small lymphnodeandfromtheperipheralblood.Thedata werecollectedbyaBDFACSCaliburcytometerand processed using the BD CellQuest software. The FCM results are shown in Fig. 4 . Analysis showed small, normal T and B lymphocytes and slightly larger,neoplasticcellsreachingupto80%and24% ofallcellsofthelymphnodeandperipheralblood, respectively. SLL diagnosis requires lymphadenopathy, no cytopenias due to bone marrow infiltration bySLL/CLLcellsandanumberofperipheralblood B-cellsinFCM<5×10 9 cells/l.Thiscasemetall these conditions. SLL cells expressed CD45 (weaker), CD19, CD20 (dim), CD23 (dim), HLA-DR (dim),CD5,CD43,CD200(higher),ZAP70,BCL-2,CD25,CD52,CD62Landkappa/IgD/IgM.The meanfluorescenceintensity(MFI)ofCD19expres-sionwashigherincomparisontoMFIofCD20.The subpopulationofSLLcellsalsorevealedtheexpres-sionofCD79β,CD38,CD11candCD71.Theneo-plasticcellswerenegativeforCD22,CD10,FMC7, lambda,IgGandIgA.
Two months after surgery, adjuvant irradiation ofthemediastinumwasperformed(totaldose5400 cGy,200cGyperfraction)duetotheadvancedstage ofthymomaandpositivesurgicalmargin.Radiotherapywascomplicatedbyslightpostradiationesophagitis. One year later progression of lymphoma with peripheral lymph node enlargement was observed. The patient received six courses of chemotherapy: rituximab,fludarabineandcyclophosphamide(R-FC) with a complete response in criteria of the RECIST 1.1 (Response Evaluation Criteria In Solid Tumors) scale.Twoyearsaftersurgeryandoneyearbeforethis reportnosignsofrecurrenceofeitherneoplasmwere observed.
Discussion
Lymphocyte-rich tumor of the anterior mediastinumalwaysrequiresdifferentiationbetweenthymoma and lymphoma. Essentially, the differentiation shouldnotbedifficult-thethymomasareepithelial Lymphocyte-richtypesofthymomascompriseB1, B2andoftenABtype.ThemorphologyofB1type canbeespeciallymisleadingandcansuggestalymphomaduetotheextremelyhighnumberoflymphocytesandinconspicuousepithelialcells.However,immunohistochemicalanti-cytokeratinstainingreveals aloosenetworkofepithelialcellsdispersedmoreor lessevenlywithinthewholetumor [4] .Anotherhistologicaltypeofthymomarichinlymphocyteswhich shouldbementionedismicronodularthymomawith lymphoidstroma.Theepithelialcellsofthisthymoma are elongated, densely packed and form small, confluentnodulesembeddedinabundantlymphoid stromawithfollicularhyperplasia.Thestromaisdevoidofepithelialcellsandlymphocytesrevealtheim-munophenotypeofB-cells,whichisanunusualphenomenon for thymomas. Ströbel et al. showed that micronodularthymomaincreasestheriskofdevelopingintrathymomatouslow-gradeB-celllymphomas ofMALTtype;however,theauthorsdidnotfindany correlationbetweenthethymomaandsystemiclymphomas [5] .
Thymomas are regarded as a risk factor for the development of an additional primary malignancy. Thedebilitationoftheprotectivefunctionofthethymus,themainimmuneorgan,byagrowingtumor, is a potential explanation of this phenomenon [1] . Second malignancies are more often metachronous thansynchronousandcandevelopyearsafterorbeforethethymictumor.Theriskofasecondneoplasia reported in different publications was between two and 18 times higher in patients with thymomas in comparisontothenormalpopulation [1, 2, 3] .Primary sites of second malignancies indicated by the authorsvariedsignificantly.TheyreportedcHLand non-Hodgkinlymphomas,aswellascancersofsolid organs:digestivesystem,lung,breast,thyroid,kidney,cervicalandprostatecarcinomas [1, 2, 3] .
Cases of collision tumors composed of thymoma andlymphomaareveryrarelydiscussedintheliterature.MostoftheminvolveT-celllymphomas(T-LBL/ ALL,peripheralT-celllymphomanototherwisespecified) [7, 8, 9, 10, 11] .Therearetwocasesofsimul-taneousthymomaandcHL [12, 13] andtwothymic epithelialtumorsaccompaniedbySLL/CLL [14, 15] . Oneofthelattercaseswasathymomacomposedof blandspindlecellsformingnests(theexacttypewas notspecified) [14] andthesecondwassquamouscell thymiccarcinoma [15] .Inbothcasesthepatientsdid not demonstrate symptoms characteristic for thymicmalignancyandmediastinaltumorswerefound duringachestexaminationperformedforotherreasons. CLL/SLL was detected fortuitously on microscopicexamination.Inourcase,thepatientsuffered from myasthenic symptoms, so the thymoma was suspected clinically. However, careful microscopic examination revealed not only a thymoma but also SLL.Toourknowledgesuchacombinationoflymphocyte-rich thymoma and small lymphocytic lymphomaisuniqueintheliterature.
Fromthetherapeuticpointofview,thecoexistence of these types of neoplasms did not create any complicationsbecausethetherapeuticapproachesdidnot interferewitheachother.Thethymomatreatmentre-quiredsurgicalresectionwithsubsequentradiotherapy,whilethelymphomaprogressionobservedoneyear laterwastreatedwithchemotherapy.Theprogression oflymphomadoesnotseemtobeinducedbyprevious irradiation.Itinvolvedmainlyperipheralratherthan mediastinal lymph nodes, and irradiation by itself is notregardedasariskfactorofSLL/CLL [16] .
Conclusions
Wehavepresentedaveryrarecaseofsimultaneous B1B2thymomaandSLLformingacollisiontumorin apatientwithmyasthenicsymptoms.Thecaseindicatesthenecessityofcarefulmicroscopicexamination supportedbyimmunohistochemicalanalysisineach caseofmediastinaltumor.Alymphocyte-richmediastinaltumorcanrepresentbothaneoplasmofactually epithelial origin such as a thymoma and a true lymphoma.Pathologistsshouldbeawareofthepossibilityofcoexistenceofbothmalignancies.
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